RN7SL182P

Across TCGA pan-cancer cohorts, RN7SL182P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL182P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RN7SL182P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL182P is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

BRCA, KIRP, and THCA are the cancer types where RN7SL182P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL182P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.151	.025	4	view →
KIRP	All	IV	−0.137	.034	2	view →
THCA	Male	III,IV	+0.144	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL182P–BRCA

Open the BRCA breakdown →